Terrence C Kearney Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Terrence C Kearney.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Terrence C Kearney. Terrence C Kearney is Director in VERTEX PHARMACEUTICALS INC / MA ($VRTX) and Director in Innoviva, Inc. ($THRX) and SVP, Finance and CFO in HOSPIRA INC ($HSP) and Director in ACCELERON PHARMA INC ($XLRN) and Director in AveXis, Inc. ($AVXS).
Terrence C Kearney in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Terrence C Kearney: Director
Holdings: 25,127 shares
Current Value: $596,515
Latest Transaction: Oct 13 2020
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Terrence C Kearney in ACCELERON PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, AVXS, HSP, THRX, VRTX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | M | 30.17 | 7,500 | 226,275 | 0 | |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | M | 27.97 | 10,000 | 279,700 | 0 | |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | M | 28.37 | 20,000 | 567,400 | 0 | |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 120.57 | 913 | 110,080 | 5,127 | 6 K to 5.1 K (-15.12 %) |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 119.78 | 16,210 | 1,941,634 | 6,040 | 22.3 K to 6 K (-72.85 %) |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 119.11 | 18,177 | 2,165,062 | 22,250 | 40.4 K to 22.3 K (-44.96 %) |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Sell | S | 117.82 | 2,200 | 259,204 | 40,427 | 42.6 K to 40.4 K (-5.16 %) |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Buy | M | 30.17 | 7,500 | 226,275 | 42,627 | 35.1 K to 42.6 K (+21.35 %) |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Buy | M | 27.97 | 10,000 | 279,700 | 35,127 | 25.1 K to 35.1 K (+39.80 %) |
| Oct 13 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Buy | M | 28.37 | 20,000 | 567,400 | 25,127 | 5.1 K to 25.1 K (+390.09 %) |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,377 | 0 | 5,127 | 3.8 K to 5.1 K (+36.72 %) |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,250 | 0 | 3,750 | 2.5 K to 3.8 K (+50.00 %) |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Grant | A | 0.00 | 1,250 | 0 | 1,250 | 0 to 1.3 K |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Kearney Terrence C | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 |
Page: 1